However, SYT11 expression in the normal and tumor tissues of the patients with BRCA, ESCA (esophageal carcinoma), GBM, NHSC, KIRC, KRIP, LIHC, LUAD, ovarian serous cystadenocarcinoma (OV), PRAD, sarcoma (SARC), stomach adenocarcinoma (STAD), thyroid carcinoma (THYM), and UCS (uterine carcinosarcoma) were not significantly different (Supplementary Fig. 1). This evidence concerns the gene SYT11 and prostate adenocarcinoma.